Home » Topics » Disease categories and therapies » Musculoskeletal

Musculoskeletal
RSS

Cyclooxygenase inhibitors synthesized at Takeda useful for inflammation, pain and fever

Dec. 5, 2001

Nexell awarded orphan drug status for stem cell product

Dec. 5, 2001

Darwin Discovery patents series of PDE7 inhibitors

Dec. 4, 2001

deCODE maps gene linked to rheumatoid arthritis

Dec. 4, 2001

New MCP-1 receptor antagonists and uses thereof claimed by Daiichi

Dec. 3, 2001

First IL-1 receptor antagonist now available for treatment of rheumatoid arthritis

Dec. 3, 2001

Pfizer reveals potential new antiinflammatory/analgesic agents

Nov. 30, 2001

Lupus kidney disease drug candidate LJP-394 designated an orphan drug in Europe

Nov. 30, 2001

Pharmacia claims new NOS inhibitors and their use in inflammation-related disorders

Nov. 29, 2001

Boehringer Ingelheim synthesizes compounds useful for inhibiting IL-2 production

Nov. 28, 2001

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 12, 2026.
Europe’s Alzecure, Orionis in $1B+ deals with Lilly, Novartis
BioWorld
Two companies with European ties signed billion-dollar deals with large pharma firms in the last two days to discover and develop molecular glue drugs, as well as...
Ethyreal launches to treat the underlying cause of Graves’, TED
BioWorld
Ethyreal Bio Inc. has come out of stealth mode in order to disclose preclinical data for ETHY-001, its monoclonal antibody targeting thyroid stimulating hormone...
Sanofi phase III CIDP quit dents Dianthus; C1 mismatch?
BioWorld
Investors in Dianthus Therapeutics Inc. apparently chose to ignore subtleties in the difference between efforts with that firm’s claseprubart vs. those by...
Jiangsu Nhwa Pharmaceutical patents new κ-opioid receptor antagonists
BioWorld Science
Jiangsu Nhwa Pharmaceutical Co. Ltd. has disclosed κ-opioid receptor antagonists that are potentially useful for the treatment of neurological disorders.